Sevelamer Carbonate Tablet, Film Coated
Product Images NDC 73190-014

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate (NDC 73190-014). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (014 27)

Sevelamer Carbonate 800 mg film-coated tablets label for oral use, manufactured by Bora Pharmaceutical Laboratories Inc. and labeled by AvKARE. The package contains 270 tablets with NDC 73190-014-27. The label includes storage instructions and dosage advisory to refer to package insert, along with typical safety warnings about moisture protection and child safety.*

FDA Label Image

Figure 1 (7397sevelamerimage 01)

Chemical structure diagram showing the polymer network of sevelamer carbonate with labeled groups indicating the number of primary amine groups, crosslinking groups, and the extended polymer network. The image illustrates key structural features of the sevelamer carbonate active ingredient.*

FDA Label Image

Figure 2 (7397sevelamerimage 02)

A line graph showing the percentage of patients with at least a twofold reduction in serum phosphorus plotted against the reduction in serum phosphorus levels (mg/dL). The graph compares Sevelamer Hydrochloride with an Active Control, illustrating changes in serum phosphorus from baseline, including worsening and improvement trends.*

FDA Label Image

Graph (7397sevelamerimage 03)

Line graph comparing phosphorus change from baseline over 52 weeks between Sevelamer Hydrochloride and an active control. The graph shows week on the x-axis and phosphorus change from baseline on the y-axis, with both treatment groups demonstrating a decrease initially, followed by stabilization.*

FDA Label Image

Figure 4 (7397sevelamerimage 04)

A forest plot figure showing subgroup analysis results comparing Sevelamer Carbonate versus placebo. The plot includes subgroups based on screening BSA, baseline serum phosphorus, age, and dialysis status, with mean differences and 95% confidence intervals displayed numerically and visually on the graph's horizontal axis from -5 to 5.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.